Novo Nordisk A/S (NVO): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Novo Nordisk A/S ( NVO) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.9%. By the end of trading, Novo Nordisk A/S fell $2.32 (-1.4%) to $162.53 on heavy volume. Throughout the day, 731,707 shares of Novo Nordisk A/S exchanged hands as compared to its average daily volume of 305,800 shares. The stock ranged in price between $161.83-$163.82 after having opened the day at $162.92 as compared to the previous trading day's close of $164.85. Other companies within the Health Care sector that declined today were: Agenus ( AGEN), down 23.4%, Genvec ( GNVC), down 10.4%, Vivus ( VVUS), down 8.9% and China Pharma ( CPHI), down 8.5%.

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. Novo Nordisk A/S has a market cap of $91.1 billion and is part of the drugs industry. Shares are up 1.0% year to date as of the close of trading on Wednesday. Currently there is 1 analyst that rates Novo Nordisk A/S a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Novo Nordisk A/S as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front, GW Pharmaceuticals PLC ADR ( GWPH), up 89.3%, Rockwell Medical ( RMTI), up 32.5%, MiMedx Group ( MDXG), up 19.8% and Echo Therapeutics ( ECTE), up 12.9% , were all gainers within the health care sector with Boston Scientific ( BSX) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Novo Nordisk Shares Leap Higher After Solid Earnings and Full-Year Sales Upgrade

Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Practices

Dow Holds Lower After House Passes Health Care Vote, Crude Falls

Daily Earnings Round-Up

5 Things You Must Know Before the Market Opens Wednesday